Enasidenib Mesylate | m-entrepreneurship.com

Product Name :
Enasidenib Mesylate

Search keywords :
IDH2

drugId :
null

Target Vo:
Isocitrate dehydrogenase [NADP], mitochondrial

Target Vo Short Name :
IDH2

Moa_Name:
Isocitrate dehydrogenase [NADP], mitochondrial inhibitors

First Approval Country :
United States

First Approval Date Filter:
2017

Origin Company_Name :
Celgene Corp

Active Company_Name :
Agios Pharmaceuticals Inc

Active Indication_Name:
Leukemia, Myeloid, Acute

In Active Indication_Name:
Lymphoma, T-Cell

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Phase 3 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
NDRG1 Rabbit mAb supplier
Phospho-FOXO3A (Ser253) Rabbit mAb manufacturer
His Tag Antibody (HRP) (YA877): His Tag Antibody (HRP) (YA877) is a HRP-conjugated, mouse-derived monoclonal antibody. His Tag Antibody (HRP) (YA877) can be used for: WB expriments in species-independent background.

Author: Betaine hydrochloride

Related Posts